Investor List:

Top BioTech Series B Investors in Raleigh-Durham / Southeast US (21)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top BioTech investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Sam Blond, Angel
Sam Blond
Angel
Sweet spot: $50K
Range: $10K - $100K
Investors in Miami (FL)
Investors in Space (Series B), Investors in BioTech (Series B), Investors in Space (Series A), Investors in Space (Seed), Investors in Health IT (Series B), Investors in Space (Pre-seed), Investors in Analytics (Series B), Investors in TransportationTech (Series A), Investors in Media/Content (Series B), Investors in BioTech (Series A), Investors in SMB Software (Series B), Investors in TransportationTech (Series B), Investors in Media/Content (Pre-seed), Investors in SMB Software (Series A), Investors in Analytics (Series A), Investors in BioTech (Pre-seed), Investors in TransportationTech (Pre-seed), Investors in Analytics (Pre-seed), Investors in Media/Content (Series A), Investors in BioTech (Seed), Investors in TransportationTech (Seed), Investors in Media/Content (Seed), Investors in Consumer Internet (Series B), Investors in Health IT (Pre-seed), Investors in Analytics (Seed), Investors in SMB Software (Pre-seed), Investors in SMB Software (Seed), Investors in AI (Series B), Investors in Health IT (Series A), Investors in Consumer Internet (Series A), Investors in Consumer Internet (Pre-seed), Investors in AI (Pre-seed), Investors in Consumer Internet (Seed), Investors in Health IT (Seed), Investors in AI (Series A), Investors in Space (Series B), Investors in AI (Seed), Investors in Space (Pre-seed), Investors in Space (Series A), Investors in TransportationTech (Pre-seed), Investors in TransportationTech (Series B), Investors in Space (Seed), Investors in Media/Content (Pre-seed), Investors in SMB Software (Pre-seed), Investors in Analytics (Series B), Investors in BioTech (Pre-seed), Investors in Analytics (Pre-seed), Investors in SMB Software (Series B), Investors in Media/Content (Series B), Investors in TransportationTech (Series A), Investors in BioTech (Series B), Investors in Health IT (Pre-seed), Investors in SMB Software (Series A), Investors in TransportationTech (Seed), Investors in Analytics (Series A), Investors in Media/Content (Series A), Investors in SMB Software (Seed), Investors in Analytics (Seed), Investors in Media/Content (Seed), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Consumer Internet (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Series B), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Consumer Internet (Series B), Investors in AI (Series A), Investors in AI (Seed), Investors in Consumer Internet (Series A), Investors in Consumer Internet (Seed), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists)
Photo of Andy Theronier, Partner at Greystone Group Inc.
Andy Theronier
Sweet spot: $1M
Range: $250K - $5.0M
Investors in New York (NY), Investors in Miami (FL), Investors in London, Investors in Hong Kong, Investors in Las Vegas (NV), Investors in Los Angeles (CA), Investors in San Diego (CA), Investors in Palo Alto (CA), Investors in Lakeland (FL), Investors in Tampa (FL), Investors in Orlando (FL)
Investors in MarketingTech (Series B), Investors in Entertainment & Sports (Series B), Investors in Education (Pre-seed), Investors in Advertising (Series A), Investors in Advertising (Pre-seed), Investors in Advertising (Series B), Investors in Advertising (Seed), Investors in Advertising (Pre-seed), Investors in Advertising (Series A), Investors in Education (Series A), Investors in MarketingTech (Series B), Investors in Education (Series B), Investors in MarketingTech (Pre-seed), Investors in Education (Seed), Investors in BioTech (Series B), Investors in Advertising (Series B), Investors in Payments (Series B), Investors in Health & Hospital Services (Series B), Investors in Advertising (Seed), Investors in Entertainment & Sports (Pre-seed), Investors in Real Estate/PropTech (Series B), Investors in Entertainment & Sports (Series A), Investors in Entertainment & Sports (Series B), Investors in Entertainment & Sports (Pre-seed), Investors in FinTech (Series B), Investors in MarketingTech (Series A), Investors in Media/Content (Series B), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Series B), Investors in MarketingTech (Pre-seed), Investors in MarketingTech (Pre-seed), Investors in Payments (Pre-seed), Investors in MarketingTech (Series A), Investors in MarketingTech (Series B), Investors in Entertainment & Sports (Seed), Investors in MarketingTech (Seed), Investors in Education (Series A), Investors in MarketingTech (Seed), Investors in BioTech (Series A), Investors in Education (Pre-seed), Investors in Payments (Series B), Investors in Payments (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Payments (Seed), Investors in MarketingTech (Series B), Investors in Payments (Series B), Investors in Education (Series B), Investors in Media/Content (Pre-seed), Investors in Real Estate/PropTech (Pre-seed), Investors in Education (Series B), Investors in Entertainment & Sports (Series A), Investors in Payments (Series A), Investors in Health IT (Pre-seed), Investors in BioTech (Pre-seed), Investors in Advertising (Series B), Investors in Entertainment & Sports (Series B), Investors in Media/Content (Pre-seed), Investors in Entertainment & Sports (Seed), Investors in MarketingTech (Pre-seed), Investors in BioTech (Series B), Investors in Media/Content (Series B), Investors in BioTech (Seed), Investors in Advertising (Series B), Investors in FinTech (Series A), Investors in Education (Seed), Investors in MarketingTech (Series A), Investors in Entertainment & Sports (Series B), Investors in Health IT (Series A), Investors in Health & Hospital Services (Pre-seed), Investors in Media/Content (Series B), Investors in Media/Content (Series A), Investors in Real Estate/PropTech (Series B), Investors in Education (Pre-seed), Investors in MarketingTech (Seed), Investors in BioTech (Series B), Investors in Advertising (Pre-seed), Investors in Real Estate/PropTech (Series A), Investors in Payments (Pre-seed), Investors in Media/Content (Seed), Investors in Payments (Seed), Investors in MarketingTech (Series A), Investors in Real Estate/PropTech (Pre-seed), Investors in Education (Series A), Investors in Real Estate/PropTech (Series A), Investors in Health IT (Pre-seed), Investors in FinTech (Pre-seed), Investors in Payments (Pre-seed), Investors in Payments (Series B), Investors in Advertising (Series A), Investors in Real Estate/PropTech (Seed), Investors in Entertainment & Sports (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Series A), Investors in Media/Content (Series A), Investors in Entertainment & Sports (Pre-seed), Investors in BioTech (Pre-seed), Investors in MarketingTech (Series B), Investors in Real Estate/PropTech (Series B), Investors in Health & Hospital Services (Pre-seed), Investors in MarketingTech (Seed), Investors in Health IT (Seed), Investors in MarketingTech (Pre-seed), Investors in Entertainment & Sports (Series A), Investors in Advertising (Seed), Investors in Health IT (Series B), Investors in FinTech (Seed), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Payments (Series A), Investors in Real Estate/PropTech (Pre-seed), Investors in Entertainment & Sports (Series B), Investors in Education (Seed), Investors in Advertising (Pre-seed), Investors in Entertainment & Sports (Series A), Investors in Education (Pre-seed), Investors in Real Estate/PropTech (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Payments (Seed), Investors in Payments (Pre-seed), Investors in Health IT (Pre-seed), Investors in Media/Content (Pre-seed), Investors in BioTech (Series B), Investors in Media/Content (Seed), Investors in Advertising (Series A), Investors in Advertising (Series B), Investors in Real Estate/PropTech (Series B), Investors in Health IT (Series B), Investors in Entertainment & Sports (Pre-seed), Investors in Payments (Series A), Investors in Education (Series B), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in MarketingTech (Series B), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Media/Content (Series B), Investors in Entertainment & Sports (Seed), Investors in Payments (Series B), Investors in Media/Content (Series A), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in FinTech (Pre-seed), Investors in Health & Hospital Services (Seed), Investors in Real Estate/PropTech (Series A), Investors in Advertising (Pre-seed), Investors in Advertising (Seed), Investors in Entertainment & Sports (Seed), Investors in Entertainment & Sports (Series B), Investors in MarketingTech (Series A), Investors in Real Estate/PropTech (Series B), Investors in Real Estate/PropTech (Seed), Investors in Payments (Seed), Investors in Health IT (Series A), Investors in Real Estate/PropTech (Pre-seed), Investors in Media/Content (Pre-seed), Investors in FinTech (Series B), Investors in Advertising (Series B), Investors in Payments (Pre-seed), Investors in Advertising (Series A), Investors in Media/Content (Seed), Investors in Education (Series B), Investors in Health IT (Seed), Investors in FinTech (Series B), Investors in MarketingTech (Seed), Investors in Real Estate/PropTech (Pre-seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Entertainment & Sports (Series A), Investors in MarketingTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in BioTech (Series A), Investors in Education (Series A), Investors in Entertainment & Sports (Pre-seed), Investors in FinTech (Pre-seed), Investors in Real Estate/PropTech (Series A), Investors in Education (Pre-seed), Investors in Payments (Series B), Investors in Media/Content (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Education (Seed), Investors in Advertising (Seed), Investors in Advertising (Pre-seed), Investors in Payments (Series A), Investors in Entertainment & Sports (Seed), Investors in FinTech (Series A), Investors in Media/Content (Series B), Investors in Media/Content (Series A), Investors in MarketingTech (Series A), Investors in FinTech (Series A), Investors in Real Estate/PropTech (Seed), Investors in BioTech (Seed), Investors in Health IT (Pre-seed), Investors in Education (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Real Estate/PropTech (Series A), Investors in BioTech (Pre-seed), Investors in Entertainment & Sports (Series A), Investors in Advertising (Series A), Investors in Payments (Seed), Investors in FinTech (Seed), Investors in Media/Content (Seed), Investors in FinTech (Seed), Investors in Real Estate/PropTech (Seed), Investors in Education (Series B), Investors in Education (Pre-seed), Investors in Health & Hospital Services (Series A), Investors in MarketingTech (Seed), Investors in Payments (Pre-seed), Investors in BioTech (Series B), Investors in FinTech (Series B), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Media/Content (Pre-seed), Investors in Education (Seed), Investors in Payments (Series A), Investors in Advertising (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series B), Investors in Entertainment & Sports (Seed), Investors in Media/Content (Series A), Investors in Media/Content (Series B), Investors in Health IT (Series B), Investors in Real Estate/PropTech (Pre-seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Health & Hospital Services (Pre-seed), Investors in FinTech (Pre-seed), Investors in Media/Content (Seed), Investors in Education (Series A), Investors in BioTech (Pre-seed), Investors in Payments (Seed), Investors in BioTech (Series A), Investors in FinTech (Pre-seed), Investors in Diverse Investors (Other Lists), Investors in FinTech (Series A), Investors in Health IT (Pre-seed), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in London (Other Lists), Investors in FinTech (Series B), Investors in Investors who invested in diverse founders (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Education (Seed), Investors in Health IT (Series A), Investors in Media/Content (Series A), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in FinTech (Seed), Investors in Health IT (Seed), Investors in Real Estate/PropTech (Series B), Investors in Media/Content (Seed), Investors in BioTech (Series A), Investors in Real Estate/PropTech (Series A), Investors in FinTech (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in FinTech (Pre-seed), Investors in Real Estate/PropTech (Seed), Investors in FinTech (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in FinTech (Series B), Investors in San Francisco Bay Area (Other Lists), Investors in FinTech (Series A), Investors in FinTech (Seed)
Photo of Scott Rocklage, Partner at 5am Ventures
Scott Rocklage
5am Ventures·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA), Investors in SF Bay Area (CA), Investors in Menlo Park (CA), Investors in Palm Beach Gardens (FL)
Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Inga Deakin, Principal at Molten Ventures
Inga Deakin
Molten Ventures·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Raleigh (NC), Investors in London
Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Digital Health (Series B), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in London (Other Lists), Investors in Health IT (Seed)
Photo of Tom Masterson, Managing Director at Allele Capital Partners
Tom Masterson
Allele Capital Partners·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Photo of David Pierson, Managing Director at Syngenta Group Ventures
David Pierson
Syngenta Group Ventures·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Durham (NC)
Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in AgTech (Series B), Investors in BioTech (Series B), Investors in E-commerce (Series B), Investors in E-commerce (Series A), Investors in AgTech (Series A), Investors in Pharmaceuticals (Seed), Investors in AgTech (Seed), Investors in BioTech (Series A), Investors in E-commerce (Seed), Investors in BioTech (Seed), Investors in AgTech (Series B), Investors in Pharmaceuticals (Series B), Investors in AgTech (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Pharmaceuticals (Series A), Investors in E-commerce (Series B), Investors in BioTech (Series B), Investors in AgTech (Seed), Investors in Pharmaceuticals (Seed), Investors in E-commerce (Series A), Investors in BioTech (Series A), Investors in E-commerce (Seed), Investors in BioTech (Seed)
Photo of Matt Hughes, Managing Director at Allele Capital Partners
Matt Hughes
Allele Capital Partners·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boca Raton (FL)
Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Seed), Investors in FinTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in FinTech (Seed), Investors in FinTech (Series A), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in BioTech (Series A), Investors in FinTech (Series B), Investors in BioTech (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed)
Photo of Ankit Bhargava, Managing Director at Allele Capital Partners
Ankit Bhargava
Allele Capital Partners·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M